{"id":5048,"date":"2023-07-25T14:36:55","date_gmt":"2023-07-25T14:36:55","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=5048"},"modified":"2023-08-05T14:49:37","modified_gmt":"2023-08-05T14:49:37","slug":"west-african-journal-of-pharmacy-2015-26-1-88-98","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2015-26-1-88-98\/","title":{"rendered":"West African Journal of Pharmacy (2015) 26 (1) 88-98"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Assessment of minilab adoption level in pharmaceutical service delivery in selected\u00a0<\/b>tertiary hospitals in south-western Nigeria.<\/b><\/p>

\u00a0<\/b><\/p>

Omoniyi J. Ola-Olorun , Margaret O. Afolabi and Timothy O. Oyebisi<\/p>

\u00a0<\/p>

Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy; African\u00a0Institute for Science Policy and Innovation, Faculty of Technology, Obafemi Awolowo University, Ile-Ife. Nigeria.<\/span><\/p>

\u00a0<\/p>

Corresponding Author: Omoniyi Ola-Olorun<\/p>

E-mail: niyiolaolorun@gmail.com Phone: +2348034119314<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Background:<\/b> One of the key strategies devised to overcome the menace of spurious medicines in\u00a0pharmaceutical distribution globally has been the invention of mobile quality assessment technology\u00a0<\/span>(Minilab\u00ae) for use along medicine supply chain in developing countries.<\/span><\/p>

Objectives:<\/b> The objectives of the study were to assess the adoption level and determine the availability of\u00a0Minilab in pharmaceutical service delivery in selected tertiary hospitals in South-western Nigeria.<\/span><\/p>

Methods:<\/b> Primary data were employed and study sample consisted of 91 pharmacists from eight of sixteen\u00a0available hospitals. Instruments employed were a set of questionnaire and physical observation of Minilab.\u00a0<\/span>The questionnaire sought to elicit information on availability of Minilab and stages of Minilab’s adoption on a\u00a0<\/span>scale of five alternative responses comprising knowledge, persuasion, decision, application and confirmation\u00a0<\/span>with weighting scores of 1 to 5. Level of adoption was computed as mean of weighted averages (MWA) of the\u00a0<\/span>respondents’ scores. Data obtained were analyzed using descriptive and inferential statistics.<\/span><\/p>

Results:<\/b> The results showed that the adoption level of Minilab was low (MWA \u22482) and Minilab was available\u00a0in three (37.5%) of the eight hospitals but used regularly in one (12.5%) only.<\/span><\/p>

Conclusion:<\/b> The study concluded that both the adoption level and availability of Minilab were low with\u00a0implications for regulatory policy.<\/span><\/p>

Key words<\/b>: Minilab, adoption level, pharmaceutical service delivery, tertiary hospital, assessment of\u00a0adoption level.<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tDownload <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Assessment of minilab adoption level in pharmaceutical service delivery in selected\u00a0tertiary hospitals in south-western Nigeria. \u00a0 Omoniyi J. Ola-Olorun , Margaret O. Afolabi and Timothy O. Oyebisi \u00a0 Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy; African\u00a0Institute for Science Policy and Innovation, Faculty of Technology, Obafemi Awolowo University, Ile-Ife. Nigeria. \u00a0 Corresponding Author: […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[234],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/5048"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=5048"}],"version-history":[{"count":4,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/5048\/revisions"}],"predecessor-version":[{"id":5054,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/5048\/revisions\/5054"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=5048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=5048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=5048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}